Comparison of ALK, RET, and ROS1 Gene Fusion Detection by Next-Generation Sequencing, Fluorescence in situ Hybridization, and Immunohistochemistry in Non-Small Cell Lung Cancer

被引：0
|
作者：
Oran, A. [1 ]
Grubb, J. [1 ]
Lieberman, D. B. [1 ]
Sussman, R. T. [1 ]
Morrissette, J. [1 ]
Rosenbaum, J. N. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2017年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST104
引用
收藏
页码：1033 / 1033
页数：1
相关论文
共 50 条
  • [31] Detection of ALK, ROS1, and RET translocations in non-small cell lung cancer (NSCLC) patients by intragenic differential expression analysis
    Cheng, Shih-Min
    Barlan, Cindy
    Hantash, Feras
    Sanders, Heather R.
    Chan, Patricia H.
    Sulcova, Vladimira
    Sanidad, Marc A.
    Qu, Kevin
    Kelly, Joann C.
    Boyar, Fatih Z.
    Sferruzza, Anthony D.
    Waldman, Frederic M.
    CANCER RESEARCH, 2014, 74 (19)
  • [32] Detecting ALK, ROS1 and RET Gene Translocations in Non Small Cell Lung Cancer (NSCLC) with the NanoString Platform
    Wang, Hangjun
    Rijk, Anke F.
    Dastani, Zari
    Agulnik, Jason
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Spatz, Alan
    van Kempen, Leon C.
    MODERN PATHOLOGY, 2017, 30 : 498A - 498A
  • [33] Detection of ALK Gene Rearrangements in Non-Small Cell Lung Cancer by Immunocytochemistry and Fluorescence in Situ Hybridization on Cytologic Samples
    Rachagiri, Suneel
    Gupta, Parikshaa
    Gupta, Nalini
    Rohilla, Manish
    Singh, Navneet
    Rajwanshi, Arvind
    TURKISH JOURNAL OF PATHOLOGY, 2022, 38 (01) : 16 - 24
  • [34] Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
    Gainor, Justin F.
    Shaw, Alice T.
    ONCOLOGIST, 2013, 18 (07): : 865 - 875
  • [35] The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
    Wojas-Krawczyk, Kamila
    Krawczyk, Pawel Adam
    Ramlau, Rodryg Adam
    Szumilo, Justyna
    Kozielski, Jerzy
    Kalinka-Warzochas, Ewa
    Bryl, Maciej
    Knopik-Nabrowicz, Alina
    Spychalski, Lukasz
    Szczesna, Aleksandra
    Rydzik, Ewelina
    Milanowski, Janusz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (06): : 484 - 492
  • [36] LORLATINIB ALK/ROS1 inhibitor Treatment of non-small cell lung cancer
    Gajdosik, Z.
    DRUGS OF THE FUTURE, 2016, 41 (12) : 715 - 723
  • [37] Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer
    Ginestet, Florent
    Lambros, Laetitia
    Le Flahec, Glen
    Marcorelles, Pascale
    Uguen, Arnaud
    CLINICAL LUNG CANCER, 2018, 19 (05) : E647 - E653
  • [38] Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization
    Diks, John
    Tang, Zhenya
    Altan, Mehmet
    Anderson, Sarah
    Chen, Hui
    Rashid, Asif
    Yang, Richard Kenneth
    Routbort, Mark J.
    Patel, Keyur P.
    Toruner, Gokce A.
    Medeiros, L. Jeffrey
    Tang, Guilin
    Luthra, Rajyalakshmi
    Roy-Chowdhuri, Sinchita
    CANCER CYTOPATHOLOGY, 2024, 132 (01) : 41 - 49
  • [39] Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma
    Brisudova, Aneta
    Skarda, Jozef
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (02): : 127 - 132
  • [40] DETECTION OF ALK GENE REARRANGEMENT IN NON-SMALL-CELL LUNG CANCER : A COMPARISON OF FLUORESCENCE IN SITU HYBRIDIZATION AND CHROMOGENIC IN SITU HYBRIDIZATION WITH CORRELATION OF ALK PROTEIN EXPRESSION
    Kim, Hyojin
    Yoo, Seol-Bong
    Choe, Ji-Young
    Paik, Jin Ho
    Xu, Xianhua
    Nitta, Hiroaki
    Chung, Jin-Haeng
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S291 - S292
12345